المؤلفون: Dirk Hose, Susanne Beck, Hans Salwender, Martina Emde, Uta Bertsch, Christina Kunz, Christoph Scheid, Mathias Hänel, Katja Weisel, Thomas Hielscher, Marc S. Raab, Hartmut Goldschmidt, Anna Jauch, Jérôme Moreaux, Anja Seckinger

المصدر: Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-12 (2019)

مصطلحات موضوعية: Multiple myeloma, Risk, Metascoring, Reporting, Survival, Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s13045-019-0750-5; https://doaj.org/toc/1756-8722

URL الوصول: https://doaj.org/article/d628a9791f6948da82e13c934ac32d97

المؤلفون: Hose, Dirk^{Aff1, Aff2}, Beck, Susanne^{Aff1, Aff2}, Salwender, Hans, Emde, Martina^{Aff1, Aff2}, Bertsch, Uta, Kunz, Christina, Scheid, Christoph, Hänel, Mathias, Weisel, Katja, Hielscher, Thomas, Raab, Marc S., Goldschmidt, Hartmut^{Aff2, Aff8}, Jauch, Anna, Moreaux, Jérôme^{Aff10, Aff11}, Seckinger, Anja^{Aff1, Aff2}

المصدر: Journal of Hematology & Oncology. 12(1)

المؤلفون: Katja Weisel, Dirk Hose, Jérôme Moreaux, Hartmut Goldschmidt, Hans Salwender, Christoph Scheid, Anna Jauch, Martina Emde, Mathias Hänel, Anja Seckinger, Susanne Beck, Christina Kunz, Uta Bertsch, Marc S. Raab, Thomas Hielscher

المساهمون: Hematology, Basic (bio-) Medical Sciences, Institut de génétique humaine (IGH), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Journal of Hematology & Oncology
Journal of Hematology & Oncology, 2019, 12 (1), ⟨10.1186/s13045-019-0750-5⟩
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-12 (2019)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Survival, [SDV]Life Sciences [q-bio], 610 Medical sciences Medicine, 0302 clinical medicine, Multiple myeloma, Metascoring, Prospective Studies, Precision Medicine, ComputingMilieux_MISCELLANEOUS, In Situ Hybridization, Fluorescence, Hematology, hematology, risk assessment, lcsh:Diseases of the blood and blood-forming organs, Induction Chemotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, 3. Good health, Brier score, 030220 oncology & carcinogenesis, Risk assessment, Risk, medicine.medical_specialty, Plasma Cells, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Multicenter trial, medicine, Internal Medicine, Humans, Multiple Myeloma/diagnosis, Molecular Biology, lcsh:RC633-647.5, business.industry, Research, Gene Expression Profiling, Induction chemotherapy, Gold standard (test), Molecular diagnostics, medicine.disease, Survival Analysis, 030104 developmental biology, Reporting, Plasma Cells/pathology, business, Transcriptome

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81d34cb9fa986bc1a3bb83183201873b
https://biblio.vub.ac.be/vubir/prospective-target-assessment-and-multimodal-prediction-of-survival-for-personalized-and-riskadapted-treatment-strategies-in-multiple-myeloma-in-the-gmmgmm5-multicenter-trial(83daf01f-93a2-4146-9187-0b3a5583bc5c).html